Drug Database · Clinicians

Lidocaine + Metronidazole + Miconazole

Also known as: lignocaine (former British name, for lidocaine)

Brands (3) Neo-Penotran Forte-L, Tri-V, Trimic Forte LShow all

Anti-protozoals/Anti-fungals/Local anesthetics; Antibiotic/Antifungal/Local anesthetic PH FDA category
Fixed-dose combination.

Rx · Prescription drug3 PH products
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Use: Xylocaine (lidocaine HCl) Injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block… US FDA label

  • Use: Intra-Abdominal Infections, including peritonitis, intra-abdominal abscess and liver abscess, caused by Bacteroides species including the B. fragilis group ( B. fragilis , B. distasonis , B. ovatus , B. thetaiotaomicron… US FDA label

    Kidney dosing: Metronidazole (single-agent)
    Show full dosing details
    CrCl ≥60 mL/min
    No dose change: kidney impairment does not alter single-dose metronidazole kinetics (label).
    CrCl 30–59 mL/min
    No dose change: kidney impairment does not alter single-dose metronidazole kinetics (label).
    CrCl 15–29 mL/min
    No dose change: kidney impairment does not alter single-dose metronidazole kinetics (label).
    CrCl <15 mL/min (not on dialysis)
    No dose change: kidney impairment does not alter single-dose metronidazole kinetics (label). In end-stage kidney disease, peak levels of hydroxy-metronidazole were 2 times and of metronidazole acetate 5 times normal (label PK). Because metabolites accumulate in end-stage kidney disease, monitoring for metronidazole-associated adverse events is recommended (label).
    Hemodialysis (intermittent)
    Hemodialysis (4 to 8 hours) removes 40% to 65% of a dose. If dosing cannot be separated from the session, consider a supplemental dose after hemodialysis (label).
    Peritoneal dialysis
    No dose change on CAPD; a 7.5-hour peritoneal dialysis removed about 10% of a dose (label).
    CRRT
    Not in label; the cited CRRT review (Li 2020) gives no regimen for this drug. Specialist input.
    • Dialyzable? Hemodialysis: yes (40% to 65% of a dose per 4- to 8-hour session, by membrane and duration). Peritoneal dialysis: little (about 10%) (label). Under 20% protein bound.
    • Monitoring Neurologic symptoms (encephalopathy, cerebellar signs, seizures, peripheral or optic neuropathy, aseptic meningitis); liver function in hepatic impairment; INR with warfarin; lithium and creatinine with lithium (label).

    From the Metronidazole monograph (renalcarematters.com, reviewed).

  • Use: Uses for the cure of most athlete's foot, jock itch and ringworm US FDA label

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Vaginal suppository: 750 mg/200 mg/100 mg

Registered products in the Philippines

3 products registered with the Food and Drug Administration (FDA) Philippines list Lidocaine + Metronidazole + Miconazole as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Also registered under: Metronodazole + Miconazole Nitrate + Lidocaine (1 product, possible match).

Verify on PH FDA portal

All registered products3
Philippine FDA-registered products for Lidocaine + Metronidazole + Miconazole
Package insert
Neo-Penotran Forte-LMetronidazole + Miconazole Nitrate + Lidocaine
750 mg/200 mg/100 mg Vaginal SuppositoryCasing Strip - PVC/PE (box of 7's)
Rx
INTERPHIL LABORATORIES, INC.Philippines
Trader: EMBIL INTERNATIONAL PHILIPPINES, INC.
DR-XY33679
Jul 27, 2027
Tri-VMetronidazole + Miconazole Nitrate + Lidocaine
750 mg / 200 mg/ 100 mg Vaginal SuppositoryPVC Coated Polyethylene Foil x 7's Box of 7's
Rx
Bliss GVS Pharma Ltd.India
Ritemed Phils., Inc.Importer: Bliss GVS Pharma Ltd
DRP-8340-01
Sep 14, 2028
Trimic Forte LMetronidazole + Miconazole Nitrate + Lidocaine
750 mg/200 mg/100 mg Vaginal SuppositoryPVC Coated Polyethylene Foil x 7's Box of 7's
Rx
Bliss GVS Pharma Ltd.India
Bliss GVS Pharma Ltd.
DRP-8340
Sep 14, 2028

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .